Literature DB >> 18262210

Voluntary alcohol consumption and plasma beta-endorphin levels in alcohol-preferring rats chronically treated with naltrexone.

Jadwiga Zalewska-Kaszubska1, Dorota Gorska, Wanda Dyr, Elzbieta Czarnecka.   

Abstract

It is well known that alcohol consumption leads to an increase in the levels of beta-endorphin (an endogenous opioid), which can contribute to the reinforcing effect of alcohol. Our previous studies have shown that repeated treatment with naltrexone, a nonselective opioid antagonist, results in increased plasma beta-endorphin levels. Ample studies in animals and humans have shown that naltrexone diminishes ethanol consumption. The aim of the present study in alcohol-preferring rats (Warsaw High Preferring; WHP) was to investigate the effect of 10 days of naltrexone treatment (2 mg/kg i.p.) on voluntary alcohol intake and on changes in plasma beta-endorphin levels while alcohol was available and 10 days after imposed abstinence. It was observed that voluntary alcohol intake induces an increase in plasma beta-endorphin levels in WHP rats. After a 10-day period of alcohol withdrawal, the levels of this peptide were significantly reduced compared with the levels in rats with free access to ethanol and in control alcohol-naïve rats. In chronic naltrexone-treated rats with free access to alcohol, an increase in the levels of this peptide was also observed; however, voluntary alcohol intake was diminished. A similar increase in plasma beta-endorphin levels was observed in naltrexone-treated rats that did not have access to ethanol. As the endogenous opioid system has an important role in the development of a craving for alcohol, it is likely that chronic naltrexone treatment may have a beneficial effect leading to a compensatory increase in the beta-endorphin concentration and ameliorating its deficiency during ethanol withdrawal. Restoring the alcohol-induced deficiency of beta-endorphin may be an important factor in the prevention of craving and maintenance of abstinence. This finding supports the proposition that the endogenous opioid system plays an important role in developing a craving for alcohol.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18262210     DOI: 10.1016/j.physbeh.2008.01.007

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  7 in total

1.  Region-specific induction of FosB/ΔFosB by voluntary alcohol intake: effects of naltrexone.

Authors:  Jing Li; Yunhui Cheng; Weiliang Bian; Xiaojun Liu; Chunxiang Zhang; Jiang-Hong Ye
Journal:  Alcohol Clin Exp Res       Date:  2010-07-09       Impact factor: 3.455

Review 2.  Rat animal models for screening medications to treat alcohol use disorders.

Authors:  Richard L Bell; Sheketha R Hauser; Tiebing Liang; Youssef Sari; Antoniette Maldonado-Devincci; Zachary A Rodd
Journal:  Neuropharmacology       Date:  2017-02-16       Impact factor: 5.250

3.  Effects of naltrexone and LY255582 on ethanol maintenance, seeking, and relapse responding by alcohol-preferring (P) rats.

Authors:  Ronnie Dhaher; Jamie E Toalston; Sheketha R Hauser; Richard L Bell; David L McKinzie; William J McBride; Zachary A Rodd
Journal:  Alcohol       Date:  2011-10-01       Impact factor: 2.405

4.  Effect of repeated treatment with topiramate on voluntary alcohol intake and beta-endorphin plasma level in Warsaw alcohol high-preferring rats.

Authors:  Jadwiga Zalewska-Kaszubska; Bartosz Bajer; Dorota Gorska; Dariusz Andrzejczak; Wanda Dyr; Przemysław Bieńkowski
Journal:  Psychopharmacology (Berl)       Date:  2012-07-31       Impact factor: 4.530

Review 5.  Scheduled access alcohol drinking by alcohol-preferring (P) and high-alcohol-drinking (HAD) rats: modeling adolescent and adult binge-like drinking.

Authors:  Richard L Bell; Zachary A Rodd; Eric A Engleman; Jamie E Toalston; William J McBride
Journal:  Alcohol       Date:  2013-10-31       Impact factor: 2.405

6.  Effects of CRF1-receptor and opioid-receptor antagonists on dependence-induced increases in alcohol drinking by alcohol-preferring (P) rats.

Authors:  Nicholas W Gilpin; Heather N Richardson; George F Koob
Journal:  Alcohol Clin Exp Res       Date:  2008-07-10       Impact factor: 3.455

Review 7.  Delta Opioid Pharmacology in Relation to Alcohol Behaviors.

Authors:  Doungkamol Alongkronrusmee; Terrance Chiang; Richard M van Rijn
Journal:  Handb Exp Pharmacol       Date:  2018
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.